Skip to main content
Back to NVIDIA

NVIDIA's Therapeutics Portfolio

Browse 4 Therapeutics companies funded by NVIDIA. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
4
Total Funding in Therapeutics
$380.1M

Therapeutics Portfolio Companies (4)

Export
Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Salt Lake City, United States
June 2024
$200.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

San Diego, United States
November 2025
$100.0M
Venture - Series Unknown

Founder Contacts

41,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife ScienceTherapeutics

Charm Therapeutics designs and develops small-molecule therapeutics that target the interaction between menin and the KMT2A protein.

London, United Kingdom
September 2025
$80.0M
Series B

Founder Contacts

41,000+ verified contacts

B2BBiotechnologyHealth CareInformation TechnologyLife SciencePharmaceuticalQuantum ComputingTherapeutics

ApexQubit is a biotechnology company that is harnessing frontier technologies for discovery of new medicines and better health for humanity.

Berkeley, United States
August 2020
$60K
Non Equity Assistance

Founder Contacts

41,000+ verified contacts

Explore NVIDIA's Full Portfolio

View all companies funded by NVIDIA across every industry and funding stage.

View Full NVIDIA Portfolio